Outcome Objectives
- Apply the latest interventional and diagnostic technologies for the management of HPV-associated head and neck cancer.
- Manage obstructive sleep apnea using appropriate guidelines for surgical intervention for this disease.
- Utilize surgical or biologic therapies for the management of chronic rhinosinusitis with nasal polyposis.
- Avoid/manage complications of endoscopic sinus surgery, including CSF leakers.
- Manage dyspnea related to upper airway stenosis.
- Incorporate lasers appropriately in office-based otolaryngology practice.
- Manage hearing loss in adults.
- Manage allergic rhinosinusitis in the pediatric population.
Accreditation / Credit Designation Statement
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 17 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Relevant Financial Relationships Statement
University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.
The following has been disclosed:
Dr. Carr: Consulting Fee-GSK (Relationship has ended)|Consulting Fee-Novartis (Relationship has ended)|Royalties or Patent Beneficiary-Wolters Kluwer- UpToDate; Dr. Chang: Grant or research support-Sanofi S.A.; Dr. Julian: Speakers Bureau-Jazz Pharmaceuticals, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca (Any division) (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board
Membership, etc.-Merck (Any division) (Relationship has ended); Dr. Weissbrod: Ownership-Channel Robotics|Stocks or stock options, excluding diversified mutual funds-FemtoVox.
All other individuals in a position to control the content of this CME activity have disclosed that they have no relevant financial relationships with ineligible companies that would constitute a conflict of interest concerning this CME activity.